ACH vs EW · rev $10.70B vs P/E 47, rev $1.39B
Accendra Health Inc (ACH) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ACH currently screens at market cap $237.8M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ACH and EW stock pages for the full models.
Not investment advice.